KPTI vs NUE · rev $68.5M vs P/E 25, rev $19.89B
Karyopharm Therapeutics Inc (KPTI) versus Nucor Corp (NUE) — a side-by-side from cached financials, not a winner call.
Karyopharm Therapeutics Inc (KPTI) is a biotechnology company listed on US.
Nucor Corp (NUE) is a steel company listed on NYSE.
Latest reported KPTI revenue for 2026-06-30 was $68.5M. Net income was -$89.4M. Revenue was up 95.3% from 2026-03-31 to 2026-06-30. KPTI currently screens at market cap $205.6M.
Latest reported NUE revenue for 2026-07-04 was $19.89B. Net income was $1.90B. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
KPTI currently screens at market cap $205.6M. NUE currently screens at market cap $57.53B and trailing P/E 25.1.
Not investment advice. Open the KPTI and NUE stock pages for the full models.
Not investment advice.